UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000022241 |
|---|---|
| Receipt number | R000025621 |
| Scientific Title | A phase II trial of Down staging Chemotherapy with Nab-paclitaxel plus Gemcitabine in patients with locally advanced pancreatic cancer |
| Date of disclosure of the study information | 2016/05/08 |
| Last modified on | 2023/04/03 20:04:24 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/05/08 19:14:46 | ||
| 2 | Update | 2017/05/10 07:41:52 | Last name of lead principal investigator Last name of lead principal investigator |
|
| 3 | Update | 2017/05/10 07:43:15 | Recruitment status |
|
| 4 | Update | 2019/11/11 08:36:12 | Date of IRB Last follow-up date |
|
| 5 | Update | 2020/04/08 08:40:04 | Recruitment status |
|
| 6 | Update | 2023/04/03 19:41:02 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Address Address Tel |
|
| 7 | Update | 2023/04/03 20:02:17 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 8 | Update | 2023/04/03 20:04:24 | Recruitment status |
